Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Less is more: patent lawyers flip the script after Amgen
Americas
Less is more: patent lawyers flip the script after Amgen
The Supreme Court’s 2023 Amgen ruling turned patent strategy upside down. Now lawyers are rethinking everything they thought they knew about protecting inventions. Marisa Woutersen reports from LSPN North America–Fall.   22 October 2025
‘Doing more with less’: In-house counsel on budgets and strategy
Biotechnology
‘Doing more with less’: In-house counsel on budgets and strategy
Chuck Scholtz, head of IP at Verdiva Bio, shares the pressures of global filing strategies on tight budgets, why there’s no ‘right way’ to manage IP, and how to get the best results from external counsel relationships.   22 October 2025
End of the ‘Death Squad’? Squires puts PTAB on trial
Americas
End of the ‘Death Squad’? Squires puts PTAB on trial
Just weeks into his tenure, USPTO director John Squires is blitzing US patent policy by taking control of how and when patent challenges can be brought, with proposed rules that could sharply limit repeat and parallel filings. Sarah Speight gauges reaction.   22 October 2025
Americas
Data and delivery: Inside AI's inventorship dilemma
Isomorphic Labs' head of IP shares why the first wave of AI-driven drug development stumbled, how data became pharma's most valuable currency, and why inventorship questions could make or break billion-dollar deals in machine learning.   21 October 2025
Careers
Weil continues expansion with top trade secrets litigator
Hire brings trade secrets and AI litigation expertise from Cooley as firm adds 14th US litigation partner this year.   21 October 2025
Americas
Top pharma, biotech, and medtech experts gather at LSPN Fall
LSIPR is gearing up for the 5th annual LSPN North America Fall Conference, starting October 21, in San Francisco, California.   21 October 2025
Americas
Mitsubishi Tanabe doubles down on Radicava protection
The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment.   20 October 2025
Americas
‘All it takes is a post on Truth Social’: Is this patent reform's moment?
A US Senate subcommittee hearing on patent eligibility reform has David Kappos, former USPTO director, believing that “there’s a better chance than ever” of a pending bill becoming law, finds Sarah Speight.   17 October 2025
Europe
Novartis fails to block repackaged imports of blockbuster treatment
The court rejected Novartis’s request for emergency measures against a Spanish importer after the pharma company failed to meet the test to enforce an injunction, the winning lawyers told LSIPR.   16 October 2025
Big Pharma
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
After saving hundreds of thousands of dollars ‘with my laptop and ChatGPT’, the biotech’s trademarks leader says lawyers need to discover how the tech can reduce external spend.   16 October 2025